Concepedia
Statistics
Publications
18
Citations
1.9K
H-Index
15
Active since
1999
Affiliations
Memorial Sloan Kettering Cancer Center(Current)
La Roche College
Icahn School of Medicine at Mount Sinai
Roche (Switzerland)
Cedars-Sinai Medical Center
Brian Higgins is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and pharmacology.
Publications per year
1999–2024
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.
Lisa M. Butler, David B. Agus, Howard I. Scher et al. · PubMed · 2000 · 617 citations
Medicine, Oncology, Pharmacology +13
17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts.
David B. Solit, Fuzhong F. Zheng, Pamela N. Münster et al. · PubMed · 2002 · 435 citations
Medicine, Oncology, Pharmacology +17
Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1.
Lukas C. Amler, David B. Agus, Charles A. LeDuc et al. · PubMed · 2000 · 150 citations
Medicine, Cell Biology, Oncology +7
Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models.
David B. Agus, Howard I. Scher, Brian Higgins et al. · PubMed · 1999 · 145 citations
Medicine, Endocrinology, Oncology +16
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase.
Lisa M. Butler, Yael Webb, David B. Agus et al. · PubMed · 2001 · 121 citations
Medicine, Oncology, Pharmacology +11
1–5 of 18